Association of vitamin D receptor and 17 hydroxylase gene polymorphisms with benign prostatic hyperplasia and benign prostatic enlargement

Urology

Volumn 57, Issue 3, 2001, Pages 567-572

  Schatzl, Georg ^a   Gsur, Andrea ^b   Bernhofer, Gabriele ^b   Haidinger, Gerald ^b   Hinteregger, Sonja ^b   Vutuc, Christian ^b   Haitel, Andrea ^b   Micksche, Michael ^b   Marberger, Michael ^a   Madersbacher, Stephan ^a,c  

^a UNIVERSITY OF VIENNA   (Austria)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c Department of Urology ^*  (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; STEROID 17ALPHA MONOOXYGENASE; VITAMIN D RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; ENDOCRINE FUNCTION; GENOTYPE; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ORGAN SIZE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; SCORING SYSTEM; STROMA; SYMPTOM; URINARY TRACT OBSTRUCTION; UROFLOWMETRY;

AGED; BIOPSY; CASE-CONTROL STUDIES; DEHYDROEPIANDROSTERONE; ESTRADIOL; FOLLICLE STIMULATING HORMONE; HUMANS; HYPERTROPHY; LUTEINIZING HORMONE; MALE; POLYMORPHISM, GENETIC; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; RECEPTORS, CALCITRIOL; STEROID 17-ALPHA-HYDROXYLASE; STEROID HYDROXYLASES; TESTOSTERONE;

EID: 0035127550     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(00)01004-9     Document Type: Article

References (35)

1. Epidemiology and natural history of benign prostatic hyperplasia
2. The prevalence of lower urinary tract symptoms in Austria as assessed by an open survey of 2096 men
3. Endocrine environment of benign prostatic hyperplasia; prostate size and volume are correlated with serum estrogen concentration
4. Serum steroids in relation to benign prostatic hyperplasia
5. Endocrine status in elderly men with lower urinary tract symptoms; correlation of age, hormonal status and lower urinary tract function
6. A prospective study of plasma hormone levels, nonhormonal factors, and development of benign prostatic hyperplasia
7. Genes involved in androgen biosynthesis and the male phenotype
8. Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2)
9. A polymorphism in the CYP17 gene is associated with prostate cancer
10. Association between CYP17 gene polymorphism and risk of breast cancer in young women
11. A polymorphism in the CYP17 gene increases the risk of breast cancer
12. Association between CYP17 polymorphisms and the development of breast cancer
13. The steroid and thyroid hormone receptor superfamily
14. Antiproliferative effects of 1,25 dihyroxyvitamin D3 on the primary cultures of human prostatic cells
15. The human prostatic carcinoma cell line LNCaP expresses biologically active, specific receptors for 1,25-didydroxyvitamin D3
16. Actions of vitamin D3, analogs on human prostate cancer cell lines; comparison with 1,25-dihydroxyvitamin D3
17. Is vitamin D deficiency a risk for prostate cancer?
18. Geographic patterns of prostate cancer mortality; evidence for a protective effect of ultraviolet radiation
19. Association of the prostate cancer with vitamin D receptor gene polymorphism
20. Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population
21. Association of prostate cancer with vitamin D receptor haplotypes in African-Americans
22. Vitamin D receptor polymorphisms, circulating vitamin D metabolites and risk of prostate cancer in United States physicans
23. Vitamin D receptor polymorphisms and prostate cancer
24. The contribution of vitamin D receptor gene alleles to the determination of bone mineral density in normal and osteoporotic women
25. Atypical adenomatous hyperplasia of the prostate; morphologic criteria for its distinction from well-differentiated carcinoma
26. Consensus statement on terminology recommendation to use atypical adenomatous hyperplasia in place of adenosis of the prostate
27. Architectural patterns of high-grade prostatic intraepithelial neoplasia
28. Polymorphism in the vitamin D receptor gene and the androgen receptor gene and the risk of benign prostatic hyperplasia
29. Localisation of the human CYP17 gene (cytochrome P45017(17alpha)) to 10q24; 3 by fluorescence in situ hybridization and simultaneous chromosome banding
30. Cloning and sequence of the human gene for p450c17(steroid 17alpha-hydroxylase/17,20 lyase); similarity with the gene for P450c21
31. Promotor-specific activation of RNA polymerase II transcription by SP1
32. Association of prostate cancer with vitamin D receptor gene polymorphism
33. Androgen receptor CAG repeat length polymorphism in benign prostatic hyperplasia (BPH); correlation with adenoma growth
34. The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia